| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品研发服务(元) | 87,159,922.89 | 220,580,521.05 | 112,164,235.54 | 264,918,075.48 | 148,889,953.70 |
| 医药商品流通(元) | 112,055,393.89 | 277,810,295.03 | 109,928,761.89 | 130,243,242.48 | 51,399,109.11 |
| 医药制造业(元) | 537,658,275.40 | 1,256,552,791.13 | 538,222,890.00 | 1,541,058,963.66 | 724,033,412.94 |
| 营业成本(元) | |||||
| 药品研发服务(元) | 66,698,634.88 | 135,414,770.03 | 73,066,709.41 | 176,168,452.39 | 92,553,246.95 |
| 医药商品流通(元) | 95,344,052.93 | 234,371,318.01 | 92,962,278.40 | 109,790,204.05 | 44,462,962.28 |
| 医药制造业(元) | 401,829,736.61 | 895,285,033.87 | 407,197,465.15 | 1,156,359,742.62 | 528,398,293.53 |
| 毛利(元) | |||||
| 药品研发服务(元) | 20,461,288.01 | 85,165,751.02 | 39,097,526.13 | 88,749,623.09 | 56,336,706.75 |
| 医药商品流通(元) | 16,711,340.96 | 43,438,977.02 | 16,966,483.49 | 20,453,038.43 | 6,936,146.83 |
| 医药制造业(元) | 135,828,538.79 | 361,267,757.26 | 131,025,424.85 | 384,699,221.04 | 195,635,119.41 |
| 毛利率(%) | |||||
| 药品研发服务(%) | 23.48 | 38.61 | 34.86 | 33.50 | 37.84 |
| 医药商品流通(%) | 14.91 | 15.64 | 15.43 | 15.70 | 13.49 |
| 医药制造业(%) | 25.26 | 28.75 | 24.34 | 24.96 | 27.02 |
| 收入构成(%) | |||||
| 药品研发服务(%) | 11.83 | 12.57 | 14.75 | 13.68 | 16.11 |
| 医药商品流通(%) | 15.21 | 15.83 | 14.46 | 6.73 | 5.56 |
| 医药制造业(%) | 72.96 | 71.60 | 70.79 | 79.59 | 78.33 |
| 毛利构成(%) | |||||
| 药品研发服务(%) | 11.83 | 17.39 | 20.90 | 17.97 | 21.76 |
| 医药商品流通(%) | 9.66 | 8.87 | 9.07 | 4.14 | 2.68 |
| 医药制造业(%) | 78.51 | 73.75 | 70.03 | 77.89 | 75.56 |